Title: Arhancet GB, et al. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation. Bioorg Med Chem Lett. 2013 Feb 15;23(4):1114-9.
133562-36-4 | 2-Amino-1-[2-(trifluoromethyl)phenyl]ethan-1-ol | AA00A2H3 | MFCD08544093
1425335-26-7 | 8-Bromo-5-fluoro-2-(trifluoromethyl)quinoline | AA00A5K8 | MFCD24386870
138371-64-9 | 2-Benzoylpyrrolidine hydrochloride | AA00A8ZV | MFCD16295304
1333240-17-7 | 2-Chloro-4,5-diMethoxy-pyriMidine | AA00AAHN | MFCD21098377
14779-55-6 | METHYLAMINE-D5 DEUTERIOCHLORIDE | AA00AB1G | MFCD00058373
174574-08-4 | 4-Methyl-5-(2-methylphenyl)-4h-1,2,4-triazole-3-thiol | AA00AB86 | MFCD03946434
1532593-30-8 | ML355 | AA00ABI2 | MFCD28167822
1884220-36-3 | Sbi-0206965 | AA00ABM8 | MFCD29472244
172426-88-9 | 3-Quinolinecarboxylic acid, 7-aMino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- | AA00ABRS | MFCD09031421
172281-72-0 | N,N-Dimethyl-1-(piperidin-4-yl)methanamine dihydrochloride | AA00AC4G | MFCD13561510